AIMMS STAR-PLUS recruitment

We are looking for highly motivated and talented MSc students who are interested in an ambitious multidisciplinary PhD project on antimicrobial research and resistance. The purpose of AIMMS STAR PLUS is to continue to educate and train Early Stage Researchers (ESRs) to become the next generation of interdisciplinary antimicrobial research scientists, skilled in the research methodologies and approaches of diverse areas such as molecular modelling, proteomics, cell signalling and drug discovery & development.

AIMMS is the Amsterdam Institute for Molecules, Medicines and Systems which started in 2012 to create a bridge between Molecular, Life, Computational Life, and Pharmaceutical Sciences at VU Amsterdam. AIMMS combines the best of these areas and is aiming at fundamental break-throughs in translational molecular medicine, drawing on the integrated study of chemical and biological processes that may lead to new drugs, biomarkers, diagnostics and patient treatments.

Co-funded by the Horizon 2020 Framework Programme of the European Union (MSCA-COFUND-2015; project # 713669)
European FlagMarieCurieCOFUND

MSCA-COFUND more information.

AIMMS STAR PLUS offers:

•    Generously funded PhD positions for 4 Early Stage Researchers (ESRs) - Appointment for 4 years
•    High profile research projects within AIMMS
•    Excellent facilities for research and education
•    Research training in both academic and industrial settings
•    Training in state-of-the-art scientific and transferable skills
•    Interactions with international collaborators & secondments in other research laboratories
•    An extensive network of national and international leading scientists
 

AIMMS STAR PLUS is looking for candidates who:

•    Are highly motivated and top-talented
•    Are able to work in a multidisciplinary team
•    Are keen on intra-European mobility to perform PhD research, specifically in Amsterdam, the Netherlands
•    Have good writing and communication skills
•    Are keen on finding solutions for solving problems related to antimicrobial resistance
 

Selection criteria of the candidate:

•    Fulfil the eligibility criteria for Marie Curie Actions - e.g. ESR, international mobility (See below)
•    Expected to obtain a certified MSc degree in Life Sciences before September 2017
•    Strong research oriented ambition and profile
•    High grades during his/her studies
•    Fluent in English
•    Preferably starting final year of Master’s study in August/September 2016

Eligibility criteria
Eligibility criteria of Marie Curie Actions apply. Only applicants who comply to the following conditions will be considered:

Conditions of experience (ESR)
The STAR-PLUS programme aims at Early Stage Researchers (ESRs) who at the time of recruitment are in the first four years of their research careers and do not have a doctoral/PhD degree.

Conditions of international mobility
Researchers supported under this scheme shall comply with the mobility rules of the Marie Skłodowska-Curie actions; Candidates should not have lived or studied for more than 12 months in The Netherlands, three years prior to starting their AIMMS STAR PLUS PhD position (i.e. from September 2014 – September 2017). Candidates at Dutch Master’s programmes will therefore be excluded from applying to the STAR-PLUS programme.

To apply for the AIMMS STAR-PLUS programme, please click here.

STAR_CallForApp_Pic1

More information

For all STAR PLUS related questions­ –or other more general questions about AIMMS- please contact:
dr Ellen Langemeijer or dr Maartje de Snoo via
  info@aimms.vu.nl

Objections

The AIMMS Management Team (MT) will be responsible to see of the selection criteria are met and if procedures are followed correctly. Students that question the evaluation process, selection criteria or feel mistreated in any other way will have the opportunity to object any decision. Within six weeks of the date of the decision, objections can be made through the AIMMS office, which will inform the AIMMS Management Team. AIMMS will confirm the objection within one week, stating whether the objection is admissible and informing about the further steps.